4.5 Article

Comparative clinical effectiveness and cost effectiveness of endovascular strategy v open repair for ruptured abdominal aortic aneurysm: three year results of the IMPROVE randomised trial

Journal

BMJ-BRITISH MEDICAL JOURNAL
Volume 359, Issue -, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/bmj.j4859

Keywords

-

Funding

  1. UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme [07/37/64]

Ask authors/readers for more resources

OBJECTIVE To assess the three year clinical outcomes and cost effectiveness of a strategy of endovascular repair (if aortic morphology is suitable, open repair if not) versus open repair for patients with suspected ruptured abdominal aortic aneurysm. DESIGN Randomised controlled trial. SETTING 30 vascular centres (29 in UK, one in Canada), 2009-16. PARTICIPANTS 613 eligible patients (480 men) with a clinical diagnosis of ruptured aneurysm, of whom 502 underwent emergency repair for rupture. INTERVENTIONS 316 patients were randomised to an endovascular strategy (275 with confirmed rupture) and 297 to open repair (261 with confirmed rupture). MAIN OUTCOME MEASURES Mortality, with reinterventions after aneurysm repair, quality of life, and hospital costs to three years as secondary measures. RESULTS The maximum follow-up for mortality was 7.1 years, with two patients in each group lost to follow-up by three years. After similar mortality by 90 days, in the mid-term (three months to three years) there were fewer deaths in the endovascular than the open repair group (hazard ratio 0.57, 95% confidence interval 0.36 to 0.90), leading to lower mortality at three years (48% v 56%), but by seven years mortality was about 60% in each group (hazard ratio 0.92, 0.75 to 1.13). Results for the 502 patients with repaired ruptures were more pronounced: three year mortality was lower in the endovascular strategy group (42% v 54%; odds ratio 0.62, 0.43 to 0.88), but after seven years there was no clear difference between the groups (hazard ratio 0.86, 0.68 to 1.08). Reintervention rates up to three years were not significantly different between the randomised groups (hazard ratio 1.02, 0.79 to 1.32); the initial rapid rate of reinterventions was followed by a much slower mid-term reintervention rate in both groups. The early higher average quality of life in the endovascular strategy versus open repair group, coupled with the lower mortality at three years, led to a gain in average quality adjusted life years (QALYs) at three years of 0.17 (95% confidence interval 0.00 to 0.33). The endovascular strategy group spent fewer days in hospital and had lower average costs of -2605 pound (95% confidence interval -5966 pound to 702) pound (about (sic) 2813; $3439). The probability that the endovascular strategy is cost effective was >90% at all levels of willingness to pay for a QALY gain. CONCLUSIONS At three years, compared with open repair, an endovascular strategy for suspected ruptured abdominal aortic aneurysm was associated with a survival advantage, a gain in QALYs, similar levels of reintervention, and reduced costs, and this strategy was cost effective. These findings support the increasing use of an endovascular strategy, with wider availability of emergency endovascular repair.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Optimizing Surveillance and Re-intervention Strategy Following Elective Endovascular Repair of Abdominal Aortic Aneurysms

Lois G. Kim, Michael J. Sweeting, David Epstein, Maarit Venermo, Fiona E. Rohlffs, Roger M. Greenhalgh

Summary: Compared with the outcomes of the EVAR-1 trial, adherence to the EVAR-1 scan protocol in simulation models reduced AAA deaths and increased elective re-interventions. The European Society re-intervention guidelines provided the most clinically effective strategy, but with an increase in re-intervention rates. Annual ultrasound in primary care was the cheapest and most cost-effective strategy that reduced AAA-related deaths.

ANNALS OF SURGERY (2021)

Letter Cardiac & Cardiovascular Systems

Estimating the Effect of Reduced Attendance at Emergency Departments for Suspected Cardiac Conditions on Cardiac Mortality During the COVID-19 Pandemic

Michail Katsoulis, Manuel Gomes, Alvina G. Lai, Albert Henry, Spiros Denaxas, Pagona Lagiou, Vahe Nafilyan, Ben Humberstone, Amitava Banerjee, Harry Hemingway, R. Thomas Lumbers

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2021)

Article Economics

An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness Analysis

Allan Wailoo, Monica Hernandez Alava, Stephen Pudney, Garry Barton, John O'Dwyer, Manuel Gomes, Lisa Irvine, David Meads, Zia Sadique

Summary: In these six countries, using EQ5D-5L compared to EQ5D-3L has a significant impact on cost-effectiveness analyses, with differences in results being large and the direction of change potentially unpredictable.

VALUE IN HEALTH (2021)

Article Multidisciplinary Sciences

Modelling the impact of changes to abdominal aortic aneurysm screening and treatment services in England during the COVID-19 pandemic

Lois G. Kim, Michael J. Sweeting, Morag Armer, Jo Jacomelli, Akhtar Nasim, Seamus C. Harrison

Summary: Efforts should be focused on encouraging men to attend AAA screening appointments post-COVID-19, and prioritizing those with AAAs on surveillance as changes to these services beyond one year are likely to have a larger impact on surgical burden and AAA-related mortality. Delaying primary screening invitations or reducing attendance could have significant negative effects on AAA-related mortality, while longer suspensions or increased drop-out rates from surveillance could greatly impact outcomes.

PLOS ONE (2021)

Letter Public, Environmental & Occupational Health

Re. Weight Change and the Onset of Cardiovascular Diseases: Emulating Trials Using Electronic Health Records Respond

Michail Katsoulis, Bianca De Stavola, Alvina G. Lai, Manuel Gomes, Karla Diaz-Ordaz

EPIDEMIOLOGY (2022)

Article Economics

Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommendations for Practice

Manuel Gomes, Elizabeth Murray, James Raftery

Summary: Digital health interventions present unique challenges for economic evaluations, requiring consideration of their distinct features in study design, measurement, analysis, and reporting. Traditional methodological standpoints may not be appropriate for digital health interventions, highlighting the need for further methodological research.

PHARMACOECONOMICS (2022)

Article Medicine, General & Internal

Barriers and facilitators of use of analytics for strategic health and care decision-making: a qualitative study of senior health and care leaders' perspectives

Elizabeth Ingram, Silvie Cooper, Sarah Beardon, Katherine Korner, Helen McDonald, Sue Hogarth, Manuel Gomes, Jessica Sheringham

Summary: This study investigates the challenges and opportunities senior leaders face when using analytics to inform healthcare decision-making. The results suggest that organizational fragmentation and concerns about data quality hinder the use of analytics, while trusted relationships and collaboration facilitate its use.

BMJ OPEN (2022)

Article Economics

Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges

Manuel Gomes, Nick Latimer, Marta Soares, Sofia Dias, Gianluca Baio, Nick Freemantle, Dalia Dawoud, Allan Wailoo, Richard Grieve

Summary: Target trial emulation (TTE) is a method used in non-randomised studies using real-world data to reduce biases, by applying design principles from randomised controlled trials (RCTs) to mimic RCT data. It helps avoid common design flaws and optimize analysis methods, providing a transparent and accessible framework to minimize confounding and assess potential limitations of real-world data in HTA decision-making.

PHARMACOECONOMICS (2022)

Review Economics

Does a working day keep the doctor away? A critical review of the impact of unemployment and job insecurity on health and social care utilisation

Keyi Li, Paula Lorgelly, Sarah Jasim, Tiyi Morris, Manuel Gomes

Summary: The impact of unemployment on health and social care utilization varies across different care settings, with a stronger association found in mental health services. Unemployed individuals are about 30% more likely to use health services compared to those employed, mainly driven by mental health service use. Factors such as financial pressure, health insurance, social network, disposable time, and depression/anxiety play a role in this association.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2023)

Article Primary Health Care

Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study

Helen Strongman, Emily Herrett, Rod Jackson, Michael Sweeting, Alexander R. Lyon, Susannah Stanway, Claire Lawson, Umesh Kadam, Liam Smeeth, Krishnan Bhaskaran

Summary: This study aimed to assess whether cancer diagnosis should be included in cardiovascular risk scores. The results showed that including a 1-year cancer survivorship variable in a QRISK3-based model met the threshold for inclusion for males, but not females. When considering cancer type, the threshold was met for both sexes with a history of haematological cancer, and for males but not females with a history of solid cancers. Developers should consider including cancer history variables in future cardiovascular risk models.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Article Multidisciplinary Sciences

STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol

Christina M. van der Feltz-Cornelis, Jennifer Sweetman, Gail Allsopp, Emily Attree, Michael G. Crooks, Daniel J. Cuthbertson, Denise Forshaw, Mark Gabbay, Angela Green, Melissa Heightman, Toby Hillman, Lyth Hishmeh, Kamlesh Khunti, Gregory Y. H. Lip, Paula Lorgelly, Hugh Montgomery, W. David Strain, Emma Wall, Caroline Watkins, Nefyn Williams, Dan G. Wootton, Amitava Banerjee, STIMULATE-ICP Consortium

Summary: As mortality rates from COVID-19 decline, the prevalence of long-term sequelae (Long COVID) is increasing and posing challenges to healthcare systems worldwide. Traditional disease-specific care pathways have been ineffective for patients with multi-morbidity, highlighting the need for a more holistic and integrated care model for the multi-system nature of Long COVID. The evolution of integrated care systems in the UK presents an important opportunity to explore areas of mutual benefit to Long COVID, multi-morbidity, and other long-term conditions.

PLOS ONE (2022)

Review Economics

The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review

Tiyi Morris, Fiona Aspinal, Jean Ledger, Keyi Li, Manuel Gomes

Summary: This study critically reviews existing literature on the impact of digital health interventions for the management of type 2 diabetes on health and social care utilization and costs. The review shows no clear evidence of an impact of digital health interventions on health and social care utilization or costs, with mixed findings reported in the included studies.

PHARMACOECONOMICS-OPEN (2023)

Article Substance Abuse

Prevalence of opioid dependence in New South Wales, Australia, 2014-16: Indirect estimation from multiple data sources using a Bayesian approach

Beatrice C. Downing, Matthew Hickman, Nicola R. Jones, Sarah Larney, Michael J. Sweeting, Yixin Xu, Michael Farrell, Louisa Degenhardt, Hayley E. Jones

Summary: This study aims to estimate the prevalence of opioid dependence in New South Wales, Australia, and found that the prevalence in 2016 was 0.92%, higher than previous estimates. Approximately one-third of the patients had no record of opioid agonist treatment in the last 4 years.

ADDICTION (2023)

Article Mathematical & Computational Biology

Addressing missing data in the estimation of time-varying treatments in comparative effectiveness research

Juan Segura-Buisan, Clemence Leyrat, Manuel Gomes

Summary: This article assesses the relative advantages of multiple imputation (MI) and inverse probability weighting (IPW) to address missing data in both outcomes and confounders measured over time. Through a comprehensive simulation study, MI consistently provided low bias and more precise estimates compared to IPW across a wide range of scenarios.

STATISTICS IN MEDICINE (2023)

Review Public, Environmental & Occupational Health

Household and area-level social determinants of multimorbidity: a systematic review

Elizabeth Ingram, Sarah Ledden, Sarah Beardon, Manuel Gomes, Sue Hogarth, Helen McDonald, David P. Osborn, Jessica Sheringham

Summary: This study systematically reviewed the associations between household and area-level social determinants of health and multimorbidity prevalence or incidence in the general population. The findings suggest that household income and area-level deprivation are significant factors associated with multimorbidity.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2021)

No Data Available